These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 20392616)

  • 1. Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease.
    Valenti L; Swinkels DW; Burdick L; Dongiovanni P; Tjalsma H; Motta BM; Bertelli C; Fatta E; Bignamini D; Rametta R; Fargion S; Fracanzani AL
    Nutr Metab Cardiovasc Dis; 2011 Aug; 21(8):568-75. PubMed ID: 20392616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HFE gene mutations and oxidative stress influence serum ferritin, associated with vascular damage, in hemodialysis patients.
    Valenti L; Valenti G; Como G; Burdick L; Santorelli G; Dongiovanni P; Rametta R; Bamonti F; Novembrino C; Fracanzani AL; Messa PG; Fargion S
    Am J Nephrol; 2007; 27(1):101-7. PubMed ID: 17299255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower serum hepcidin and greater parenchymal iron in nonalcoholic fatty liver disease patients with C282Y HFE mutations.
    Nelson JE; Brunt EM; Kowdley KV;
    Hepatology; 2012 Nov; 56(5):1730-40. PubMed ID: 22611049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blunted increase in serum hepcidin as response to oral iron in HFE-hemochromatosis.
    Sangwaiya A; Manglam V; Busbridge M; Thursz M; Arnold J
    Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):721-4. PubMed ID: 21654321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HFE mutations modulate the effect of iron on serum hepcidin-25 in chronic hemodialysis patients.
    Valenti L; Girelli D; Valenti GF; Castagna A; Como G; Campostrini N; Rametta R; Dongiovanni P; Messa P; Fargion S
    Clin J Am Soc Nephrol; 2009 Aug; 4(8):1331-7. PubMed ID: 19541813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlates of hepcidin and NTBI according to HFE status in patients referred to a liver centre.
    Ryan E; Ryan JD; Russell J; Coughlan B; Tjalsma H; Swinkels DW; Stewart S; Crowe JP
    Acta Haematol; 2015; 133(2):155-61. PubMed ID: 25277871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemochromatosis (HFE) genotype and atherosclerosis: Increased susceptibility to iron-induced vascular damage in C282Y carriers?
    Engberink MF; Povel CM; Durga J; Swinkels DW; de Kort WL; Schouten EG; Verhoef P; Geleijnse JM
    Atherosclerosis; 2010 Aug; 211(2):520-5. PubMed ID: 20400082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum hepcidin and macrophage iron correlate with MCP-1 release and vascular damage in patients with metabolic syndrome alterations.
    Valenti L; Dongiovanni P; Motta BM; Swinkels DW; Bonara P; Rametta R; Burdick L; Frugoni C; Fracanzani AL; Fargion S
    Arterioscler Thromb Vasc Biol; 2011 Mar; 31(3):683-90. PubMed ID: 21183736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease.
    Valenti L; Fracanzani AL; Bugianesi E; Dongiovanni P; Galmozzi E; Vanni E; Canavesi E; Lattuada E; Roviaro G; Marchesini G; Fargion S
    Gastroenterology; 2010 Mar; 138(3):905-12. PubMed ID: 19931264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased iron burden in overweight C282Y homozygous women: Putative role of increased hepcidin production.
    Desgrippes R; Lainé F; Morcet J; Perrin M; Manet G; Jezequel C; Bardou-Jacquet E; Ropert M; Deugnier Y
    Hepatology; 2013 May; 57(5):1784-92. PubMed ID: 23322654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum hepcidin levels are innately low in HFE-related haemochromatosis but differ between C282Y-homozygotes with elevated and normal ferritin levels.
    van Dijk BA; Laarakkers CM; Klaver SM; Jacobs EM; van Tits LJ; Janssen MC; Swinkels DW
    Br J Haematol; 2008 Sep; 142(6):979-85. PubMed ID: 18557745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis.
    Valenti L; Pulixi EA; Arosio P; Cremonesi L; Biasiotto G; Dongiovanni P; Maggioni M; Fargion S; Fracanzani AL
    Haematologica; 2007 Aug; 92(8):1037-42. PubMed ID: 17640859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hepcidin gene promoter nc.-1010C > T; -582A > G haplotype modulates serum ferritin in individuals carrying the common H63D mutation in HFE gene.
    Silva B; Pita L; Gomes S; Gonçalves J; Faustino P
    Ann Hematol; 2014 Dec; 93(12):2063-6. PubMed ID: 25015054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver.
    Bugianesi E; Manzini P; D'Antico S; Vanni E; Longo F; Leone N; Massarenti P; Piga A; Marchesini G; Rizzetto M
    Hepatology; 2004 Jan; 39(1):179-87. PubMed ID: 14752836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis.
    Fargion S; Mattioli M; Fracanzani AL; Sampietro M; Tavazzi D; Fociani P; Taioli E; Valenti L; Fiorelli G
    Am J Gastroenterol; 2001 Aug; 96(8):2448-55. PubMed ID: 11513189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum prohepcidin concentration: no association with iron absorption in healthy men; and no relationship with iron status in men carrying HFE mutations, hereditary haemochromatosis patients undergoing phlebotomy treatment, or pregnant women.
    Roe MA; Spinks C; Heath AL; Harvey LJ; Foxall R; Wimperis J; Wolf C; Fairweather-Tait SJ
    Br J Nutr; 2007 Mar; 97(3):544-9. PubMed ID: 17313717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of iron status on vascular health.
    Yunker LM; Parboosingh JS; Conradson HE; Faris P; Bridge PJ; Buithieu J; Title LM; Charbonneau F; Verma S; Lonn EM; Anderson TJ
    Vasc Med; 2006 May; 11(2):85-91. PubMed ID: 16886838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver steatosis correlates with iron overload but not with HFE gene mutations in chronic hepatitis C.
    Sikorska K; Stalke P; Romanowski T; Rzepko R; Bielawski KP
    Hepatobiliary Pancreat Dis Int; 2013 Aug; 12(4):377-84. PubMed ID: 23924495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study.
    Valenti L; Fracanzani AL; Dongiovanni P; Bugianesi E; Marchesini G; Manzini P; Vanni E; Fargion S
    Am J Gastroenterol; 2007 Jun; 102(6):1251-8. PubMed ID: 17391316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver transplantation normalizes serum hepcidin level and cures iron metabolism alterations in HFE hemochromatosis.
    Bardou-Jacquet E; Philip J; Lorho R; Ropert M; Latournerie M; Houssel-Debry P; Guyader D; Loréal O; Boudjema K; Brissot P
    Hepatology; 2014 Mar; 59(3):839-47. PubMed ID: 23775519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.